PEAK6 Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

PEAK6 Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,900	Closed	-$3.29M	–	5168
2017 Q4	$3.29M	Buy	24,900 +16,500	+196%	+$1.94M	0.02%	1071
2017 Q3	$853K	Sell	8,400 -5,200	-38%	-$557K	﹤0.01%	2102
2017 Q2	$1.36M	Sell	13,600 -1,900	-12%	-$204K	0.01%	1670
2017 Q1	$1.88M	Buy	+15,500	New	+$1.9M	0.02%	1189
2016 Q4	–	Sell	-9,300	Closed	-$1.23M	–	5248
2016 Q3	$1.23M	Buy	+9,300	New	+$889K	0.01%	1612
2015 Q4	–	Sell	-5,000	Closed	-$457K	–	5516
2015 Q3	$457K	Sell	5,000 -17,600	-78%	-$1.96M	﹤0.01%	2956
2015 Q2	$2.78M	Sell	22,600 -26,200	-54%	-$2.97M	0.02%	1228
2015 Q1	$4.45M	Buy	+48,800	New	+$3.96M	0.03%	747
2014 Q4	–	Sell	-19,400	Closed	-$1.57M	–	5320
2014 Q3	$1.57M	Sell	19,400 -46,000	-70%	-$4.07M	0.01%	1456
2014 Q2	$7.02M	Buy	65,400 +62,000	+1,824%	+$4.31M	0.07%	368
2014 Q1	$202K	Buy	+3,400	New	+$202K	﹤0.01%	3424

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PEAK6 Group's GWPH Position: Q2 2018 in Review

PEAK6 Group reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 43% in Q2 2018, selling an estimated $485K and leaving 4,476 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

PEAK6 Group first reported a position in GWPH in Q2 2015 and has held it in 5 quarters since. The position peaked at $889K in Q1 2018. 254 funds tracked by Wall St. Rank hold GWPH as of Q2 2018.

PEAK6 Group held 4,476 shares of GW Pharmaceuticals Plc American Depositary Shares worth $625K as of Q2 2018.
PEAK6 Group sold 3,416 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2018, an estimated $485K.
GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2382 holding.
PEAK6 Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and has held it in 5 quarters since.
PEAK6 Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $889K in Q1 2018.
254 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.